Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer. [electronic resource]
Producer: 20210406Description: 46-54 p. digitalISSN:- 1872-8332
- Adenocarcinoma of Lung -- drug therapy
- Aged
- Aged, 80 and over
- Biomarkers, Tumor -- genetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib -- therapeutic use
- DNA, Neoplasm -- analysis
- Diagnostic Tests, Routine
- Exons
- Female
- Follow-Up Studies
- High-Throughput Nucleotide Sequencing
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Retrospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.